Elotuzumab
AbbVie,BMS
['choice i', 'mmsm']
should we use kpd as maintenance in high risk patients? ajay nooka says yes.. i agree we need better maintenance in high risk patients. a promising choice in a challenging disease to treat. #asco23 #mmsm #mediq23asco 
We empower people at every level of the healthcare delivery system with the knowledge needed to continuously improve provider performance and patient outcomes.